Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sarepta Therapeutics
Sarepta Therapeutics
Sarepta's AdCom Needs FDA's Permission To Speak Freely
Forbes
Mon, 05/16/16 - 11:55 am
Sarepta Therapeutics
FDA
eteplirsen
3 Risky Biotechs With FDA Decisions On Deck
Motley Fool
Fri, 05/13/16 - 10:08 am
FDA
Sarepta Therapeutics
eteplirsen
Synergy Pharmaceuticals
plecanatide
Celator
Vyxeos
What's Sarepta Therapeutics Inc.'s Next Move?
Motley Fool
Tue, 05/10/16 - 09:43 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta: The Path Forward
Seeking Alpha
Wed, 05/4/16 - 08:52 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Why it took so long for Sarepta to start a big trial of its Duchenne drug
Bizjournals.com
Tue, 05/3/16 - 05:15 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
clinical trials
Sarepta Therapeutics shares surge 20% after article suggests drug approval possible
Marketwatch
Thu, 04/28/16 - 09:36 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
FDA
advisory panels
eteplirsen
Here Are Three Ways To Prevent Tragic Battles Between The FDA And Patients
Forbes
Wed, 04/27/16 - 09:06 am
FDA
patients
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
Biotech stock crashes 50% after disclosing bad news from the FDA
Yahoo/Business Insider
Tue, 04/26/16 - 09:45 am
Sarepta Therapeutics
eteplirsen
FDA
Duchenne Muscular Dystrophy
FDA panel votes against Sarepta’s drug for Duchenne muscular dystrophy
Stat
Mon, 04/25/16 - 09:57 pm
FDA
Sarepta Therapeutics
eteplirsen
advisory panels
Duchenne Muscular Dystrophy
Sarepta Therapeutics FDA Panel Live Blog
TheStreet.com
Mon, 04/25/16 - 08:21 am
Sarepta Therapeutics
eteplirsen
FDA
advisory panels
Duchenne Muscular Dystrophy
An Investors' Guide to Sarepta's Eteplirsen FDA Advisory Panel Meeting
TheStreet.com
Mon, 04/25/16 - 07:56 am
Sarepta Therapeutics
eteplirsen
FDA
advisory panels
Duchenne Muscular Dystrophy
Could Desperate Parents' Pleas Sway The FDA To Approve A Drug Even If Evidence It Works Is Lacking?
Forbes
Sun, 04/24/16 - 04:32 pm
FDA
parents
Duchenne Muscular Dystrophy
Sarepta Therapeutics
eteplirsen
Biotech Stock Mailbag: Is There a Future for Sarepta Therapeutics?
TheStreet.com
Fri, 04/22/16 - 10:40 am
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
FDA Still Negative on Sarepta's DMD Drug, Stock Price Sinks
TheStreet.com
Thu, 04/21/16 - 08:45 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
2 FDA Actions To Watch In April
Seeking Alpha
Mon, 03/28/16 - 09:12 pm
FDA
Sarepta Therapeutics
eteplirsen
Mycapssa
Chiasma
acromegaly
Duchenne Muscular Dystrophy
Summit develops a unique Duchenne drug for any gene mutation
Bizjournals.com
Sat, 03/26/16 - 12:59 pm
Summit Therapeutics
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Sarepta surges as a group of expert doctors endorses its investigational DMD drug
Bidness, ETC
Tue, 03/22/16 - 10:00 am
physicians
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Of These 5 Hated Biotech Stocks, Only 1 Is a Potential Disaster in the Making
Motley Fool
Fri, 03/18/16 - 10:38 am
INSYS Therapeutics
MannKind
Relypsa
Ziopharma Oncology
Sarepta Therapeutics
FDA sets new date for hearing on Sarepta’s Duchenne drug
Bizjournals.com
Thu, 03/10/16 - 09:57 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta shrinks as execs wait for FDA's decision on Duchenne drug
Fierce Biotech
Wed, 03/9/16 - 10:38 am
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
eteplirsen
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »